AUB ScholarWorks
Efficacy and mechanism of action of the mammalian target of rapamycin (mTOR) inhibitor RAD001 in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia-lymphoma - by Ansam Abdul Hafiz Sinjab
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Sinjab, Ansam Abdul Hafiz |
| dc.date.accessioned | 2012-06-13T07:35:06Z |
| dc.date.available | 2012-06-13T07:35:06Z |
| dc.date.issued | 2010 |
| dc.identifier.uri | http://hdl.handle.net/10938/8542 |
| dc.description | Thesis (M.S.)--American University of Beirut, Dept. of Biology, 2010.;"Advisor : Dr. Nadine Darwiche, Professor, Biology--Co-Advisor :Dr. Ali Bazarbachi, Professor , Internal Medicine--Member of Committee : Dr.Khouzama Knio, Professor ,Biology--Member of |
| dc.description | Bibliography : leaves 88-106. |
| dc.description.abstract | HTLV-I associated adult T-cell leukemia-lymphoma (ATL) and HTLV-I-negative peripheral T-cell lymphomas carry poor prognosis mainly due to acquired resistance to chemotherapy. The mammalian Target of Rapamycin (mTOR) is a serine-threonine kinase and a key |
| dc.format.extent | xviii, 106 leaves : ill. 30 cm. |
| dc.language.iso | eng |
| dc.relation.ispartof | Theses, Dissertations, and Projects |
| dc.subject.classification | T:005390 AUBNO |
| dc.subject.lcsh | Rapamycin |
| dc.subject.lcsh | Adult T-cell leukemia |
| dc.subject.lcsh | HTLV-I (Virus) |
| dc.subject.lcsh | Leukemia |
| dc.subject.lcsh | Lymphomas |
| dc.subject.lcsh | Cancer cells |
| dc.title | Efficacy and mechanism of action of the mammalian target of rapamycin (mTOR) inhibitor RAD001 in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia-lymphoma - by Ansam Abdul Hafiz Sinjab |
| dc.type | Thesis |
| dc.contributor.department | American University of Beirut. Faculty of Arts and Sciences. Department of Biology |
